Table 2.
Clinical manifestations associated with the clinical strains included in this study
| Sample | Clinical manifestations | Strains typed in this study | Strains typed by Coipan et al. [15] | Strains extracted from the MLST database | Total |
|---|---|---|---|---|---|
| Skin biopsy | EM | 43 | 98 | 49 | 190 |
| MEM | 7 | – | – | 7 | |
| ACAa | 8 | 26 | 7 | 41 | |
| BLa | 3 | – | 5 | 8 | |
| Morphea | – | – | 1 | 1 | |
| Unspecified | – | – | 35 | 35 | |
| CSF | NBa | – | – | 20 | 20 |
| Joints | LAa | 1 | – | 1 | 2 |
| Muscle biopsy | Fasciitisa | 1 | – | – | 1 |
| Blood | Bacteremiaa | – | – | 1 | 1 |
| Unknown | – | – | – | 2 | 2 |
| Disseminated manifestationsa | 20 | 26 | 34 | 80 | |
| Total | 63 | 124 | 121 | 308 | |
Abbreviations: EM, erythema migrans; MEM, multiple erythema migrans; ACA, acrodermatitis chronica atrophicans; NB, neuroborreliosis; BL, borrelial lymphocytoma
aManifestations corresponding to a disseminated form of Lyme borreliosis